Working together for better care: The latest Clinical Service Excellence Programme (CSEP) Awards
This quarter we’ve seen the power of community in action across myeloma services, with teams aligning pathways, sharing learning and improving care together – all reflected in the latest Clinical Service Excellence Programme (CSEP) accreditations and reaccreditations.
New accreditations
King’s College Hospital, Princess Royal University Hospital and Milton Keynes Hospital.
Reaccreditations
Royal United Hospital Bath, Salisbury District Hospital and University College London Hospital.
CSEP supports hospitals to deliver compassionate, personalised myeloma care and recognises services that go above and beyond. Our accredited network continues to grow and is suitable for hospitals of all sizes – from district generals to large teaching hospitals.
If you are interested in joining the CSEP community, complete our short application form to start the process or contact the team at CSEP@myeloma.org.uk.
Celebrating the newest accredited hospitals
King’s College Hospital, London and Princess Royal University Hospital, Orpington, Kent
King’s College Hospital and Princess Royal University Hospital approached CSEP accreditation in tandem, demonstrating commitment to aligning their services and providing cohesive support for myeloma patients across King’s College Hospital NHS Foundation Trust. Their collaboration is also evident in the way colleagues from both sites work with multiple specialist MDTs – including renal, bone and regional neuropathy – ensuring patients benefit from joined-up expertise.
Community support extends beyond the clinic too, with patients coming together to attend meetings of the South-East London Myeloma Support Group, re-established in 2024 by the team at King’s. Alongside the strong community focus, both hospitals offer an extensive clinical trial portfolio, giving patients access not only to the range of approved treatments but also novel treatments not yet routinely available on the NHS.
Each site also demonstrated their own notable strengths. At King’s College Hospital, investment in service development means every newly diagnosed myeloma patient now receives a full holistic needs assessment, providing early, personalised support at a crucial stage of their diagnosis and treatment. At Princess Royal University Hospital, the consultants work closely with local GP colleagues to improve identification of plasma cell disorders and to optimise the MGUS pathway, helping ensure patients are referred and supported as early as possible.
Milton Keynes Hospital
Milton Keynes Hospital demonstrates a clear commitment to building a supportive community for people with myeloma. The onsite wellbeing team plays a central role in this offering access to a range of support services, including psychology, dietetics and physiotherapy. There are also regular art therapy sessions, movement groups and even a choir, providing a chance for patients to enjoy creative activities together that improve wellbeing. These activities give patients the chance to connect with others, build confidence and improve their wellbeing through shared experiences.
Alongside this community-focused support, Milton Keynes Hospital continues to prioritise access to clinical trials. The hospital’s extensive portfolio offers options for patients at key stages of disease and across different myeloma subtypes – ensuring as many people with myeloma as possible can benefit from innovative and emerging treatments.
Celebrating reaccreditations
Royal United Hospital Bath
Royal United Hospital Bath continues to demonstrate clinical excellence through strong multidisciplinary working and innovation. A key example of this is the recently established ‘myeloma one-stop clinic’. Patients with two-week referrals are triaged and referred to this clinic where they receive a consultation, bone marrow aspirate and trephine biopsy, and a CT-PET scan, all on the same day. This coordinated approach has improved the 28-day diagnostic target, and patient experience has been positive.
Community support is also central to the service. The team has introduced an educational meeting for newly diagnosed myeloma patients and their families, bringing together the myeloma CNS, therapies team, clinical psychologist, Macmillan support team and local myeloma support group. After a year of running, feedback has been excellent, reflecting the value of shared understanding and connection at the point of diagnosis.
Salisbury District Hospital
Salisbury District Hospital’s reaccreditation reflects the strength of a service committed to sustained development and initiative to see positive change for people living with myeloma. Since their first accreditation, the team has undertaken substantial service development to offer stem cell transplantation (SCT) on-site. This change means myeloma patients no longer need to travel to University Hospital Southampton, reducing travel burden and improving continuity of care.
The hospital has also established a dedicated myeloma lead clinician and myeloma clinic, facilitating more robust case management, data collection, and a better understanding of myeloma-specific service development needs. In turn, this ensures patients receive more streamlined, coordinated care.
University College London Hospital
University College London Hospital (UCLH) continue to demonstrate the impact of integrating specialist services to support holistic myeloma care. A standout strength is the integrated prehabilitation and rehabilitation pathway for patients undergoing SCT, designed to enhance patient resilience, optimise recovery, and improve long-term outcomes.
The team also work closely with neurology and other specialists to support people with related conditions, including POEMS syndrome. The team run the UK’s only POEMS syndrome clinic, offering haematology- and neurology-specialist appointments, accepting national referrals, publishing research and contributing to national clinical guidelines.
The impact of collaboration
Each of these hospitals have demonstrated clinical excellence across the board to achieve CSEP accreditation or reaccreditation. They also highlight how collaboration and shared expertise are creating change and shaping myeloma care across the UK.
Join the CSEP community and be part of the change.
Find out more about CSEP, or to start the process, complete our short application form or contact the team at CSEP@myeloma.org.uk.
